Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control

F Betül Kavun Ozbayraktar1, Kutlu O Ulgen

  • 1Department of Chemical Engineering, Bogazici University, 34342 Bebek, Istanbul, Turkey. betulkavun@gmail.com

Insights

This study identifies novel cancer drug targets by analyzing the sphingolipid pathway. Computational tools pinpoint enzymes that, when manipulated, can lead to ceramide accumulation for cancer therapy.

Area of Science:

  • Biochemistry
  • Systems Biology
  • Cancer Research

Background:

  • Sphingolipids play a critical role in cell fate and function, significantly impacting cancer development and progression.
  • Understanding the sphingolipid metabolic pathway is essential for developing novel cancer therapeutics that target these pathways.
  • Pharmacological manipulation of sphingolipid metabolism offers a promising avenue for cancer treatment.

Purpose of the Study:

  • To identify potential drug target enzymes within the sphingolipid pathway for cancer therapy using computational systems biology tools.
  • To rank enzymes based on their control over the metabolic network and identify functionally significant pathway modules.
  • To select candidate enzymes whose manipulation results in ceramide accumulation and long-chain base phosphates depletion.

Main Methods:

  • Utilized two computational systems biology tools for analyzing the sphingolipid metabolic network.
  • Applied metabolic control analysis to rank enzymes by their influence on the metabolic network.
  • Employed metabolic pathway analysis to identify biologically significant and functionally connected reaction modules.

Main Results:

  • Identified and ranked enzymes within the sphingolipid pathway based on their metabolic control.
  • Determined physiologically connected reactions, representing functional modules of the network.
  • Selected candidate drug target enzymes predicted to induce ceramide accumulation and deplete long-chain base phosphates.

Conclusions:

  • Computational systems biology tools are effective for identifying drug targets in the sphingolipid pathway for cancer therapy.
  • The identified candidate enzymes provide a basis for drug design studies aimed at cancer treatment.
  • The study's approach was validated using clinically available drugs, confirming the efficiency of the mathematical tools.